New Key Statistics Module, Z-Score and F-Score
FRA:CDC Key Ratios
| Market Cap € M | 1.29 |
| Enterprise Value € M | 7.97 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 11.50 |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) € M | -- |
| EPS (TTM) € | -0.04 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 25.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.61 |
| EV-to-EBITDA | -2.61 |
| PEG | -- |
| Shares Outstanding M | 36.78 |
| Net Margin (%) | -- |
| Operating Margin % | -- |
| Pre-tax Margin (%) | -- |
| Quick Ratio | 4.40 |
| Current Ratio | 4.40 |
| ROA % (ttm) | -122.81 |
| ROE % (ttm) | -153.51 |
| ROIC % (ttm) | -2,032.86 |
| Dividend Yield % | -- |
| Altman Z-Score | -- |
FRA:CDC Number of Guru Trades
FRA:CDC Volume of Guru Trades
Gurus Latest Trades with FRA:CDC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
FRA:CDC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers